3Hus WH, Huang CS, Hus HS, et al. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer[J]. Ann Thorac Surg, 2007,83(2) : 419-424.
4Molina R, Filella X, Auge JM. ProGRP: a new biomarker for small cell lung cancer[J]. Clinical Biochem, 2004,37 (7) : 505- 511.
5Lamy PJ, Grenier J, Kramar A, et al. Pro-gastrin-releasing peptide,neuron specific enolase and chromogranin A as serum markers of small cell Lung cancer[J]. Lung Cancer, 2000,29 (3) : 197-203.
6Niklinski J, Furman M, Jaroszewiez E. Cyfra 21-1 : new marker for non-small cell lung cancer[J]. Pneumonol Alergol Pol, 1994,62(5/6) :227-232.
7Pavicevic R, Bubanovic G, Franjevic A, et al. CYFRA21-1 in non-small ceil lung cancer-standardisation and application during diagnosis[J]. Coll Antropol, 2008,32 (2) : 485-489.
7Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [ J ]. CA Cancer J Clin,2005 ,55( 2 ) :74 - 108.
8Shimanuki Y, Akahash IK, Ui R, et al. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer [ J ]. Lung,2005,183 ( 1 ) :29 - 42.
9Takahashi Y, Kitadai Y, Beana CD, et al. Expression of vascular endothelial growth factor and its receptor KDR. correlates with vascularity, metastasis and proliferation of human colon cancer [ J ]. Cancer Res, 1995,55 ( 18 ) :3964 - 3968.
10Kulpa J, Wojcik E, Reinfuss, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA21-1, and neuron-specific enolase in squamous cell lung cancer patients [ J ]. Clin Chem, 2002,48 (11) :1931 -1937.
6Hatzidaki D,Agelaki S,Mavroudis D. A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer[J].Clin Lung Cancer,2006,(01):49-55.
7Yoshida K,Sugiura T,Takifuji N. Randomized phase Ⅱ trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer:JCOG 9515[J].{H}Lung Cancer,2007,(03):362-368.
8Cusumano G,Margarifora S,Porziella V. Malignant Pleural Effusion[J].{H}Annali Italiani Di Chirurgia,2007,(05):389-391.
9Ebert W,Hoppe M,Muley T. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA21-1,TPATP CEA and NSE[J].Anti Cancer Res,1997,(04):2875-2877.
